Login
$VMD
$9.14 -$0.03 (0.33%) Live

$VMD 8-K SEC Filings

Filed On Filing
04 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Lafayette, Louisiana (November 4, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it ...

20 Aug 2026 8-K: Regulation FD Disclosure

A Rapidly Growing National Leader In Home-Based Clinical Care. Investor Presentation: NASDAQ: VMD August 2026 VieMed Healthcare Inc. • Investor Presentation 1

03 Aug 2026 8-K: Results of Operations and Financial Condition

Lafayette, Louisiana (August 3, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it ha...

04 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

The Viemed Healthcare, Inc. 2024 Long Term Incentive Plan ( as previously amended, the “Plan”) is hereby amended, effective June 4, 2026, if approved by the Company’s shareholders at the annual general and special meeting of shareholders...

02 Jun 2026 8-K: Regulation FD Disclosure

A Rapidly Growing National Leader In Home-Based Clinical Care. Investor Presentation: NASDAQ: VMD June 2026 VieMed Healthcare Inc. • Investor Presentation 1

05 May 2026 8-K: Results of Operations and Financial Condition

Lafayette, Louisiana (May 5, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has r...

16 Mar 2026 8-K: Regulation FD Disclosure

A Rapidly Growing National Leader In Home-Based Clinical Care. Investor Presentation: NASDAQ: VMD March 2026 VieMed Healthcare Inc. • Investor Presentation 1

04 Mar 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

Lafayette, Louisiana (March 4, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it ha...

07 Nov 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD November 2025 VieMed Healthcare Inc. • Investor Presentation

05 Nov 2025 8-K: Results of Operations and Financial Condition

Lafayette, Louisiana (November 5, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today...

23 Sep 2025 8-K: Regulation FD Disclosure; Other Events

LAFAYETTE, La., (September 23, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases au...

06 Aug 2025 8-K: Results of Operations and Financial Condition

Lafayette, Louisiana (August 6, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced today t...

02 Jul 2025 8-K: Regulation FD Disclosure

LAFAYETTE, Louisiana (July 2, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it ...

09 Jun 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure +1 more

Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD June 2025 VieMed Healthcare Inc. • Investor Presentation

05 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

The Viemed Healthcare, Inc. 2024 Long Term Incentive Plan (the “Plan”) is hereby amended, effective June 5, 2025, if approved by the Company’s shareholders at the annual general and special meeting of shareholders on June 5, 2025, for Aw...

07 May 2025 8-K: Results of Operations and Financial Condition

LAFAYETTE, Louisiana (May 7, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its f...

06 May 2025 8-K: Regulation FD Disclosure

LAFAYETTE, Louisiana (May 6, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it h...

14 Apr 2025 8-K: Departure/Election of Directors or Officers; Compensation

On April 14, 2025, Bruce Greenstein notified Viemed Healthcare, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors, effective immediately. At the time of his resignation, Mr. Greenstein served as Chairma...

18 Mar 2025 8-K: Regulation FD Disclosure

Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD March 2025 VieMed Healthcare Inc. • Investor Presentation

10 Mar 2025 8-K: Results of Operations and Financial Condition

Lafayette, Louisiana (March 10, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported it...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support